All In Biotech

Drug Trial Radar · NCT07694297

Phase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients With Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure

A Phase 2, Multicenter, Open-label Study to Evaluate Safety and Efficacy of 500 mg BID NTZ on Top of Standard of Care in Patients With Inflammatory Phenotype Presenting Either With Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure (CONTROL-ACLF)

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

16

Planned (sponsor's estimate)

Start

Oct 16, 2026

Primary completion

Aug 2027

Study completion Dec 2027

Sponsor

Lead sponsor
GenfitIndustry
Sponsor type
Industry
First posted
Jul 9, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients with Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure

Conditions

  • Acute Decompensation of Liver Cirrhosis
  • Established Acute-on-Chronic Liver Failure

Interventions

  • NTZ 500mg BID on top of SOCDrug

    Treatment period NTZ 500mg BID on top of SOC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the safety of 500 mg BID NTZ administered perorallyTime frame: over 7 days on top of SOC follow-up period up to Day 28.

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • JSC Georgian Clinics, 2, Otskheli street

    Kutaisi, Georgia · Not yet recruiting

  • American Hospital Network LLC, N58 Dimitri Uznadze Street

    Tbilisi, Georgia · Not yet recruiting

  • New Hospitals LLC, 12 Krtsanisi street/71 Gorgasali street

    Tbilisi, Georgia · Not yet recruiting

  • Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, LLC,9 Tsinandali str.

    Tbilisi, Georgia · Not yet recruiting

  • K. Eristavi National Center of Experimental and Clinical Surgery, 7 Chachava street

    Tbilisi, Georgia · Not yet recruiting

  • Geo Hospitals LLC, 9-3 Tsinandali street

    Tbilisi, Georgia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.